Results 111 to 120 of about 474,198 (345)

Advanced Oral Delivery Systems for Nutraceuticals

open access: yesAdvanced Healthcare Materials, EarlyView.
Emerging delivery technologies are explored to overcome barriers to oral nutraceutical absorption. Traditional carriers are compared with novel platforms including biodegradable polymers, MOFs, MPNs, and 3D printing. These systems enhance bioavailability, control release, and enable personalized nutrition.
Xin Yang   +4 more
wiley   +1 more source

Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease [PDF]

open access: green, 2000
Kejal Kantarci   +10 more
openalex   +1 more source

Functional hubs in mild cognitive impairment [PDF]

open access: yes, 2015
We investigate how hubs of functional brain networks are modified as a result of mild cognitive impairment (MCI), a condition causing a slight but noticeable decline in cognitive abilities, which sometimes precedes the onset of Alzheimer's disease.
Bajo Breton, Ricardo   +8 more
core   +2 more sources

Redox‐Active Polyphenol Red Molecularly Imprinted Polymers on Porous Gold Electrodes for Ultrasensitive, AI‐Assisted Detection of Alzheimer's Biomarkers in Undiluted Biofluids

open access: yesAdvanced Healthcare Materials, EarlyView.
This work presents a low‐cost, reagent‐free point‐of‐care biosensor integrating redox‐active polyphenol red molecularly imprinted polymers (pPhR MIPs) on highly porous gold (HPG) electrodes for ultrasensitive detection of phosphorylated tau 181 (p‐Tau 181), an Alzheimer’s disease biomarker, in undiluted biofluids.
Sudhaunsh Deshpande   +4 more
wiley   +1 more source

Network Structure of Depressive Symptomatology in Elderly with Cognitive Impairment

open access: yesMedicina
Objective and objectives: Patients with cognitive disorders such as Alzheimer’s disease (AD) and mild cognitive impairment (MCI) frequently exhibit depressive symptoms. Depressive symptoms can be evaluated with various measures and questionnaires.
Jeehyung Pyo   +7 more
doaj   +1 more source

Spontaneous speech based web screening test for MCI. [PDF]

open access: yes, 2014
Background / Aim Even today there is a great diagnostic uncertainty in the prodromal stages of Alzheimer’s disease (AD). Our recent effort has focused on the very earliest detectable indicators of cognitive decline in mild cognitive impairment (MCI ...
Hegyi, Ágnes   +4 more
core  

Harnessing Photo‐Energy Conversion in Nanomaterials for Precision Theranostics

open access: yesAdvanced Materials, EarlyView.
Harnessing photo‐energy conversion in nanomaterials enables precision theranostics through light‐driven mechanisms such as photoluminescence, photothermal, photoelectric, photoacoustic, photo‐triggered surface‐enhanced Raman scattering (SERS), and photodynamic processes. This review explores six fundamental principles of photo‐energy conversion, recent
Jingyu Shi   +4 more
wiley   +1 more source

Linear and Symmetric Artificial Synapses Driven by Hydrogen Bonding for Accurate and Reliable Neuromorphic Computing

open access: yesAdvanced Materials, EarlyView.
Hydrogen‐bond‐driven interface engineering enables highly linear and symmetric artificial synapses based on CsPbI3–PVA hybrids. This strategy suppresses trap states and guides directional ion migration, yielding stable optoelectronic plasticity. The devices achieve ultralow power operation and human‐like learning in neuromorphic networks, offering a ...
Min Jong Lee   +10 more
wiley   +1 more source

Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED] [PDF]

open access: bronze, 2001
Ronald C. Petersen   +5 more
openalex   +1 more source

Lithium‐Charged Gold Nanoparticles: A New Powerful Tool for Lithium Delivery and Modulation of Glycogen Synthase Kinase 3 Activity

open access: yesAdvanced Materials, EarlyView.
This study introduces glutathione‐stabilized gold nanoparticles for targeted lithium delivery (LiG‐AuNPs), enabling the controlled modulation of Glycogen Synthase Kinase‐3 (GSK‐3β). These non‐toxic, 2‐nm particles release lithium intracellularly, effectively inhibiting GSK‐3β in the brain without significant plasma lithium alterations.
Antonio Buonerba   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy